Evaluate provides a view of the pharmaceutical market through solutions that combine technology, real world data, and analytics to assist in making portfolio decisions in the biopharma industry.

Evaluate

Evaluate Pharma & Evaluate Omnium

Evaluate Medtech

EvaluateCustomSolutions

Evaluate provides trusted commercial intelligence and predictive analytics for the pharmaceutical industry. We help our clients to refine and transform their understanding of the past, present and future of the global pharmaceutical market to drive better decisions. 

Evaluate solutions give you the time and confidence to turn understanding into insight, and insight into action:

Evaluate Omnium - provides a complete, dynamic view of development risk and commercial return across the full clinical lifecycle, delivering game-changing insight into pharma asset potential.

EvaluatePharma - the trusted global view of the pharmaceutical market’s past, present and future performance with consensus forecasts to 2026, company financials, pipelines, deals and more. @EvaluatePharma 
 
EvaluateMedTech - tracks, benchmarks, and forecasts global performance for the medical device and diagnostic industry with consensus forecasts to 2024, company financials and more.

Evaluate Custom Solutions -  improve your strategic decision-making with customised solutions and deep insights that draw on our industry expertise and trusted commercial intelligence. 

Explore Evaluate at  www.evaluate.com
Twitter: @EvaluatePharma




Advera Health Analytics

Mercury

Evaluate Ltd

As we launched into 2024, hopes were moderately high for dealmaking and investment in #pharma. What was the score at the halfway point in the year? Our new eBook digs into the detail behind the headline figures of a very bumpy recovery. https://ow.ly/LsAt50STztr

What’s the secret formula for creating the next #pharmaceutical behemoth? https://ow.ly/oJL150SPSXJ

Download Evaluate's latest #eBook and discover whether indication expansion drives revenue growth, the pros and cons of in-house vs. outsourced development, and more.

Missed our webinar about #AI in #pharma forecasting? Fear not, we have a blog post with a few highlights for you. And the webinar featuring J+D Forecasting is available on-demand! https://ow.ly/m8Eq50SSYHR

Screening and valuing #pharma assets can be a thorny path, with so many data points to work through. Evaluate Ltd's solutions provide an accurate, impartial, and timely view of pharma #asset potential. Find out more: https://lnkd.in/eseaFYEz

Missed this? Now's the time to catch up on the latest #pharma forecasts with our World Preview #report. Download the full report here: https://lnkd.in/gMe5hqD7

What’s the secret formula for creating the next #pharmaceutical behemoth? https://lnkd.in/gCusCD2U

Download Evaluate Ltd's latest #eBook and discover whether indication expansion drives revenue growth, the pros and cons of in-house vs. outsourced development, and more.

news_impact_assignment_basic

key_people

network_dossier

public_peers

news_daily_refresh

news_processing_daily_refresh

news_impact_assignment_daily

news_processing_basic

legal

legal_dossier

bundesanzeiger

events_dossier

partnerships_market_presence_dossier

partnerships_market_presence

company_dossier

network

strategic_challenges

industry_trends

strategic_challenges_dossier

industry_trends_dossier

company_summary

events

network_mapping

transactions_dossier

swot_dossier

merger_acquisitions

signals

financial_statements

crunchbase_trigger

crunchbase_profile

li_profile

financials_download_nd

private_financials

swot_analysis

financial_legal_advisories

company_structure

industry_analysis

financial_analysis

funding_rounds_analysis

regulatory_analysis

competition_analysis

news_impact_assignment_advanced

news_processing_advanced

news_advanced

purchaser_profile

network_onboarding

translate_crunchbase_fundingrounds

peers

customer_profile

news_basic

valuation

news impact assignment basic	general
public peers	general	Aug 12, 2024 7:15 AM	2d512d00
news daily refresh	general
news processing daily refresh	general
news impact assignment daily	general
news processing basic	general
company summary	general
signals	general
crunchbase trigger	general
crunchbase profile	general
li profile	general	Aug 12, 2024 7:15 AM	6fe9579c
translate crunchbase fundingrounds	general
peers	general	Aug 12, 2024 7:15 AM	457a1cbb
news basic	general	Aug 12, 2024 7:15 AM	b4a33459
bundesanzeiger	filings
merger acquisitions	company_analysis
financials download nd	financials
private financials	financials

EVAL

COM:EVALUATE

Evaluate